4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-058365
CBO & EVP acquired 109,734 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kassberg Thomas Richard · CBO & EVP
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-30 | Exercise or conversion : show line 1 in the form | +109,734 | $0.31 | $34,018 | 216,552 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-30 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −109,734 | 0 | D |
Loading xslF345X03/doc4.xml…